Internal Portfolio Development
Our mission is to work with scientists and clinicians at UPMC and any other academic or innovative institution to commercialize translational science, launch successful start-up companies, create partnerships and licensing opportunities with big pharma, and invest alongside top investors in external companies that complement our strategic focus.
The Beginning
Launched 17 projects in 2017 with $200M in funding
Initiated with a focus in Immune Therapy & Transplant
A small team formed to commercialize leading-edge science
The Evolution
Additional funding ($1B total) in 2020 has enabled diverse set of investments
Spans early discovery to clinical initiation
Diligence in external investments complements internal pipeline and vice versa
Rigorous scientific, technical, and business diligence applied
Industry standard planning & execution ensure expeditious progress
What makes us successful?
Centers of Excellence and Expertise (University of Pittsburgh, Carnegie Mellon University)
An end-to-end UPMC ecosystem (basic science to payor)
Breadth and volume of innovation
Ability to rapidly convert information to knowledge that shapes the opportunity
Translational Sciences Team (diverse, seasoned, and nimble)
Ability to develop and execute industry standard translational plans
Looking to the future
Expansion of team to grow internal pipeline
Greater outreach, beyond UPMC and University of Pittsburgh
Proactive idea intake and call for proposals
Commercial exits in addition to company formation
Building additional development capabilities
- Manufacturing partners
- Nonclinical development
- Clinical and regulatory expertise